CapsoVision to Release Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 26, 2026

About this update from Capsovision, Inc.

[{"type":"image","alt":"CapsoVision","displaySize":"","headline":null,"caption":"CapsoVision","className":"","disableSlideshowImg":false,"size":{"original":{"width":289,"height":82,"url":"https://media.zenfs.com/en/globenewswire.com/7997fdcf01bc3e4679fd070889da0319"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/jJl.NIPxE32l94ZCZ8MnHQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExOTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/7997fdcf01bc3e4679fd070889da0319","width":289,"height":82}},"lazy":false},{"type":"text","content":"Conference Call Scheduled for Thursday, March 26, 2026, at 4:30 pm ET","length":69,"tagName":"p"},{"type":"text","content":"SARATOGA, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced that the company will release fourth quarter and full year 2025 financial results on Thursday, March 26, 2026, after the close of market. CapsoVision will host a corresponding conference call and a live webcast at 1:30 pm PT / 4:30 pm ET on the same day to discuss the results and provide a corporate update.","length":527,"tagName":"p"},{"type":"text","content":"Individuals interested in listening to the conference call may do so by dialing (800) 715-9871 for domestic callers or (646) 307-1963 for international callers and referencing conference ID 2525025, or from the webcast link on the Events page in the investor relations section of the company’s website. To access the replay, please register via the webcast link on the Events page. The webcast will be available for one year following the completion of the call.","length":464,"tagName":"p"},{"type":"text","content":"About CapsoVision","length":17,"tagName":"p"},{"type":"text","content":"CapsoVision is a commercial-stage medical technology company focused on developing advanced imaging and AI-enabled solutions to transform the detection and screening of gastrointestinal diseases. Its flagship product, CapsoCam Plus®, is a wire-free, panoramic capsule endoscope that enables high-resolution visualization of the small bowel and supports cloud-based or direct capsule video retrieval. The Company’s next pipeline product, CapsoCam Colon™ with enhanced AI, is designed to enable non-invasive colon imaging and polyp detection. With a proprietary p...

More updates from Capsovision, Inc.